Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TSXV/TTI stock hub

TSXV/TTI has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TSXV/TTIis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

29M

TSX Venture Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TSXV/TTI

In the news

Latest news · TSXV/TTI

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROE-371.3

P25 -121.5P50 -40.9P75 0.5

ROIC-231.1

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TSXV/TTI market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

123

Groups with data

Currency

CAD

Showing 123 of 123 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Enterprise value	CAD 27.4M
Exchange	TSX Venture Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Biotechnology
Last refreshed	2026-05-10
Market cap	CAD 29M
Price	CAD 0.56
Price currency	CAD
Sector	Healthcare
Sic	2836
Symbol	tsxv/TTI
Website	https://www.thiogenesis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-25.58%
EV Earnings	-3.69x
P/B ratio	50.54x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	CAD -7.4M
ROA	-159.4
Roa5y	-204.9
ROCE	-1,287.5
ROE	-371.3
ROIC	-231.1

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-9.68%
Cagr3y	-8.46%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	CAD 1.8M
Cash	CAD 1.6M
Current Assets	CAD 1.8M
Current Liabilities	CAD 1.2M
Equity	CAD 574,377
Liabilities	CAD 1.2M
Long Term Assets	CAD 0
Long Term Liabilities	CAD 0
Net Cash	CAD 1.6M
Net Cash By Market Cap	CAD 5.57
Net Cash Growth	-58%
Net Debt Equity	CAD -2.81
Tangible Book Value	CAD 574,377
Tangible Book Value Per Share	CAD 0.01
WACC	7.14

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.46
Net Working Capital	CAD -1M
Quick ratio	1.36
Working Capital	CAD 574,377

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-7.11%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-9.68%
200-day SMA	0.67
3Y total return	-23.29%
50-day SMA	0.53
50-day SMA vs 200-day SMA	50under200
All Time High	1.06
All Time High Change	-47.17%
All Time High Date	2024-01-22
All Time Low	0.38
All Time Low Change	49.33%
All Time Low Date	2022-07-15
ATR	0.03
Beta	0.53
Beta1y	0.43
Beta2y	0.37
Ch YTD	-13.85
High	0.56
High52	0.88
High52 Date	2025-07-07
High52ch	-36.36%
Low	0.56
Low52	0.44
Low52 Date	2026-03-24
Low52ch	27.27%
Ma50ch	5.03%
Price vs 200-day SMA	-16.05%
RSI	53.39
RSI Monthly	42.91
RSI Weekly	44.83
Sharpe ratio	0.33x
Sortino ratio	0.59
Total Return	-7.11%
Tr YTD	-13.85
Tr1m	14.29%
Tr1w	3.7%
Tr3m	-10.4%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -7.4M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	43,076,887%
Shares Insiders	16.9%
Shares Out	51,835,956
Shares Qo Q	3.55%
Shares Yo Y	7.11%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	34,929.15x
Bv Per Share	0.01
Ch1m	14.29
Ch1w	3.7
Ch1y	-9.68
Ch3m	-10.4
Ch3y	-23.29
Ch6m	-25.33
Change	3.7%
Change From Open	0
Close	0.54
Days Gap	3.7
Dollar Volume	1,120
Earnings Date	2026-05-22
EBIT	CAD -7.4M
EPS	CAD -0.15
F Score	1
Financing CF	3,811,610
Fiscal Year End	December
Is Primary Listing	1
Last Earnings Date	2025-11-17
Last Report Date	2025-12-31
Ma150	0.63
Ma150ch	-10.57%
Ma20	0.56
Ma20ch	0.09%
Net CF	-2,231,898
Next Earnings Date	2026-05-22
Open	0.56
Price Date	2026-05-08
Ptbv Ratio	50.54
Relative Volume	0.06x
Share Based Comp	774,217
Tr6m	-25.33%
Volume	2,000

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TSXV/TTI pay a dividend?

Capital-return profile for this ticker.

Performance

TSXV/TTI stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TSXV/TTI?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+16.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+7.1%

Negative means the company is buying back shares.

Technical

TSXV/TTI momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

53.4

Neutral momentum band

Price vs 200-day MA

-16.1%

50/200-day relationship not available

Beta (5Y)

0.53

Less volatile than the market

Sharpe ratio

0.33

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TSXV/TTI

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tsxv/TTI stock rating?

tsxv/TTI is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tsxv/TTI analysis?

The full report lives at /stocks/tsxv/TTI/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tsxv/TTI?

The latest report frames tsxv/TTI around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tsxv/TTI page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.